GLP-1 medicationsshort for glucagon-like peptide-1 receptor agonistsare prescription drugs that help regulate appetite, slow digestion, and improve blood sugar control
You're a member of our Del Mar community, and you can always speak to a real person at our clinic who knows your name and your story
What happens if I stop treatment
Liraglutide vs Semaglutide vs GLP-1 for Weight Loss Liraglutide and semaglutide GLP-1 are both GLP-1 receptor agonists that aid in weight loss by controlling appetite and regulating blood sugar levels, but semaglutide GLP-1 has shown greater efficacy in clinical studies

In experimental systems, it has been examined for its influence on multiple physiological processes relevant to energy balance : Glucose regulation : Studied for glucose-dependent stimulation of insulin secretion and suppression of glucagon release Gastrointestinal function : Investigated for delayed gastric emptying and altered gastrointestinal motility Energy intake and body weight : Evaluated in large phase 2 and 3 research programs, including the STEP (SemaglutidE Treatment Effect in People with obesity) trial series Cardiometabolic markers : Examined for changes in blood pressure, lipid parameters, and inflammatory biomarkers Renal and hepatic endpoints : Explored as secondary or exploratory outcomes in selected studies Within laboratory environments, Semaglutide (20 mg) is commonly used for: In vitro GLP-1 receptor signaling assays Pancreatic islet and -cell biology studies Preclinical models of food intake and body-weight regulation Formulation, stability, and delivery-technology research All applications remain investigational and are conducted under controlled research conditions
